Literature DB >> 28880746

Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer.

Allen S Ho1, Sungjin Kim1, Mourad Tighiouart1, Cynthia Gudino1, Alain Mita1, Kevin S Scher1, Anna Laury1, Ravi Prasad1, Stephen L Shiao1, Jennifer E Van Eyk1, Zachary S Zumsteg1.   

Abstract

Purpose Current staging systems for oral cavity cancers incorporate lymph node (LN) size and laterality, but place less weight on the total number of positive metastatic nodes. We investigated the independent impact of numerical metastatic LN burden on survival. Methods Adult patients with oral cavity squamous cell carcinoma undergoing upfront surgical resection for curative intent were identified in the National Cancer Data Base between 2004 and 2013. A neck dissection of a minimum of 10 LNs was required. Multivariable models were constructed to assess the association between the number of metastatic LNs and survival, adjusting for factors such as nodal size, laterality, extranodal extension, margin status, and adjuvant treatment. Results Overall, 14,554 patients met inclusion criteria (7,906 N0 patients; 6,648 node-positive patients). Mortality risk escalated continuously with increasing number of metastatic nodes without plateau, with the effect most pronounced with up to four LNs (HR, 1.34; 95% CI, 1.29 to 1.39; P < .001). Extranodal extension (HR, 1.41; 95% CI, 1.20 to 1.65; P < .001) and lower neck involvement (HR, 1.16; 95% CI, 1.06 to 1.27; P < .001) also predicted increased mortality. Increasing number of nodes examined was associated with improved survival, plateauing at 35 LNs (HR, 0.98; 95% CI, 0.98 to 0.99; P < .001). In multivariable models accounting for the number of metastatic nodes, contralateral LN involvement (N2c status) and LN size were not associated with mortality. A novel nodal staging system derived by recursive partitioning analysis exhibited greater concordance than the American Joint Committee on Cancer (8th edition) system. Conclusion The number of metastatic nodes is a critical predictor of oral cavity cancer mortality, eclipsing other features such as LN size and contralaterality in prognostic value. More robust incorporation of numerical metastatic LN burden may augment staging and better inform adjuvant treatment decisions.

Entities:  

Mesh:

Year:  2017        PMID: 28880746      PMCID: PMC5791830          DOI: 10.1200/JCO.2016.71.1176

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   50.717


  28 in total

1.  Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes.

Authors:  R P Meijer; R P P Meijer; C J M Nunnink; A E Wassenaar; A Bex; H G van der Poel; B W van Rhijn; W Meinhardt; S Horenblas
Journal:  J Urol       Date:  2011-12-15       Impact factor: 7.450

Review 2.  Current state of neck dissection in the United States.

Authors:  Raja R Seethala
Journal:  Head Neck Pathol       Date:  2009-08-07

3.  Multiple imputation of discrete and continuous data by fully conditional specification.

Authors:  Stef van Buuren
Journal:  Stat Methods Med Res       Date:  2007-06       Impact factor: 3.021

4.  Nodal yield and survival in oral squamous cancer: Defining the standard of care.

Authors:  Ardalan Ebrahimi; Wan J Zhang; Kan Gao; Jonathan R Clark
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

Review 5.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

6.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

7.  Determinants of lymph node count in endometrial cancer surgical staging.

Authors:  Beatrice Cormier; Philippe Sauthier; Christian Lussier; Geng Zang; Marie-Helene Mayrand
Journal:  Int J Gynecol Cancer       Date:  2012-10       Impact factor: 3.437

8.  Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).

Authors:  Vasu Divi; Jonathan Harris; Paul M Harari; Jay S Cooper; Jonathan McHugh; Diana Bell; Erich M Sturgis; Anthony J Cmelak; Mohan Suntharalingam; David Raben; Harold Kim; Sharon A Spencer; George E Laramore; Andy Trotti; Robert L Foote; Christopher Schultz; Wade L Thorstad; Qiang Ed Zhang; Quynh Thu Le; F Christopher Holsinger
Journal:  Cancer       Date:  2016-07-15       Impact factor: 6.860

9.  Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer.

Authors:  Vasu Divi; Michelle M Chen; Brian Nussenbaum; Kim F Rhoads; Davud B Sirjani; F Christopher Holsinger; Jennifer L Shah; Wendy Hara
Journal:  J Clin Oncol       Date:  2016-11-10       Impact factor: 44.544

10.  Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.

Authors:  Wayne M Koch; John A Ridge; Arlene Forastiere; Judith Manola
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-09
View more
  54 in total

1.  Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.

Authors:  Z S Zumsteg; M Luu; S Kim; M Tighiouart; A Mita; K S Scher; D J Lu; S L Shiao; J Mallen-St Clair; A S Ho
Journal:  Ann Oncol       Date:  2019-01-01       Impact factor: 32.976

2.  Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.

Authors:  Lei Huang; Odile David; Robert J Cabay; Klara Valyi-Nagy; Virgilia Macias; Rong Zhong; Barry Wenig; Lawrence Feldman; Ralph Weichselbaum; Michael T Spiotto
Journal:  Clin Cancer Res       Date:  2018-12-20       Impact factor: 12.531

3.  Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary.

Authors:  Won Ki Cho; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-19       Impact factor: 4.553

4.  18F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer.

Authors:  Mi Rye Bae; Jong-Lyel Roh; Jae Seung Kim; Jeong Hyun Lee; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-12       Impact factor: 4.553

5.  Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Authors:  Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger
Journal:  J Clin Oncol       Date:  2019-02-27       Impact factor: 44.544

6.  Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer.

Authors:  Yeonjoo Choi; Manal Bin-Manie; Jong-Lyel Roh; Kyung-Ja Cho; Yoon Se Lee; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-07-27       Impact factor: 4.553

7.  Nodal grouping in nasopharyngeal carcinoma: prognostic significance, N classification, and a marker for the identification of candidates for induction chemotherapy.

Authors:  Yifei Liu; Shenghuan Chen; Annan Dong; Fei Ai; Tingting Quan; Chunyan Cui; Jian Zhou; Shaobo Liang; Jiamin Wang; Shunxin Wang; Ling Hua; Shuoyu Xu; Mingyuan Chen; Ying Sun; Haojiang Li; Lizhi Liu
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

8.  Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer.

Authors:  Heiko Schöder; Paula Demétrio De Souza França; Reiko Nakajima; Eva Burnazi; Sheryl Roberts; Christian Brand; Milan Grkovski; Audrey Mauguen; Mark P Dunphy; Ronald A Ghossein; Serge K Lyashchenko; Jason S Lewis; Joseph A O'Donoghue; Ian Ganly; Snehal G Patel; Nancy Y Lee; Thomas Reiner
Journal:  Clin Cancer Res       Date:  2020-04-03       Impact factor: 12.531

9.  Development of a novel salivary gland cancer lymph node staging system.

Authors:  Katri Aro; Allen S Ho; Michael Luu; Sungjin Kim; Mourad Tighiouart; Jon Mallen-St Clair; Emi J Yoshida; Stephen L Shiao; Ilmo Leivo; Zachary S Zumsteg
Journal:  Cancer       Date:  2018-05-09       Impact factor: 6.860

10.  Society of Behavioral Medicine position statement: Society of Behavioral Medicine supports oral cancer early detection by all healthcare providers.

Authors:  Caryn E Peterson; Sara C Gordon; Charles W Le Hew; J A Dykens; Gina D Jefferson; Malavika P Tampi; Olivia Urquhart; Mark Lingen; Karriem S Watson; Joanna Buscemi; Marian L Fitzgibbon
Journal:  Transl Behav Med       Date:  2019-07-16       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.